Related Articles Saroglitazar, a novel cardiometabolic agent for diabetic dyslipidemia – A Review Pharmacokinetic Evaluation of Paclitaxel in South Indian Cancer Patients: A Prospective Study Share 0 FacebookTwitterLinkedinEmail Previous Article Next Article